Physician Perspectives on Vaccination in Patients With Autoimmune Inflammatory Rheumatic Diseases: An International Survey
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Philip | - |
dc.contributor.author | Winthrop, Kevin | - |
dc.contributor.author | Sawalha, Amr H. | - |
dc.contributor.author | Choi, Serim | - |
dc.contributor.author | Park, Hyun Ah | - |
dc.contributor.author | Hwang, Woochang | - |
dc.contributor.author | Lee, Eun Bong | - |
dc.contributor.author | Park, Jin Kyun | - |
dc.date.accessioned | 2023-05-03T09:55:07Z | - |
dc.date.available | 2023-05-03T09:55:07Z | - |
dc.date.created | 2023-03-08 | - |
dc.date.issued | 2023-02 | - |
dc.identifier.issn | 0315-162X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/184958 | - |
dc.description.abstract | OBJECTIVE: To evaluate the perspective of physicians who care for patients with autoimmune inflammatory rheumatic disease (AIIRD) toward vaccination. METHODS: Physicians who care for patients with AIIRD were invited to participate in an online survey regarding their vaccination perspectives in adult patients with AIIRD. RESULTS: Survey responses of 370 physicians from Asia (41.1%), North America (41.6%), Europe (13.8%), and other countries (3.5%) were analyzed. Participants stated that rheumatologists (58.2%) should be primarily responsible for vaccination coverage, followed by general internists (19.3%) and family medicine practitioners (12.8%). Additionally, 96.7% of participants considered vaccination very important (≥ 4/5 rating) for patients with AIIRD. Despite these sentiments, only one-third (37%) reported vaccinating the majority (≥ 60%) of their patients. CONCLUSION: Physicians who care for patients with AIIRD agree that vaccines are effective and safe in patients with AIIRD. Unfortunately, they often do not ensure that their patients are adequately vaccinated. Further studies are needed to investigate how to improve vaccination coverage for this high-risk patient population. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | J RHEUMATOL PUBL CO | - |
dc.title | Physician Perspectives on Vaccination in Patients With Autoimmune Inflammatory Rheumatic Diseases: An International Survey | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hwang, Woochang | - |
dc.identifier.doi | 10.3899/jrheum.220135 | - |
dc.identifier.scopusid | 2-s2.0-85147317450 | - |
dc.identifier.wosid | 000936516300016 | - |
dc.identifier.bibliographicCitation | JOURNAL OF RHEUMATOLOGY, v.50, no.2, pp.246 - 251 | - |
dc.relation.isPartOf | JOURNAL OF RHEUMATOLOGY | - |
dc.citation.title | JOURNAL OF RHEUMATOLOGY | - |
dc.citation.volume | 50 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 246 | - |
dc.citation.endPage | 251 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | ARTHRITIS | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | COVERAGE | - |
dc.subject.keywordPlus | INFLUENZA | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | autoimmune disease | - |
dc.subject.keywordAuthor | guideline | - |
dc.subject.keywordAuthor | immunosuppressant | - |
dc.subject.keywordAuthor | survey | - |
dc.subject.keywordAuthor | vaccination | - |
dc.identifier.url | https://www.jrheum.org/content/50/2/246 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.